Showing results (101-110 of 164) with videos related to
Sort By:
Pageof 17
Oncotarget|February 5, 2011
Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndromeEmmanuel Raffoux, Audrey Cras, Christian Recher, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia GroupLionel Adès, Sylvie Chevret, Emmanuel Raffoux, et al.Blood|April 17, 2015
Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemiaYves Chalandon, Xavier Thomas, Sandrine Hayette, et al.American Journal of Hematology|April 9, 2013
Long-term follow-up of European APL 2000 trial, evaluating the role of cytarabine combined with ATRA and Daunorubicin in the treatment of nonelderly APL patientsLionel Adès, Sylvie Chevret, Emmanuel Raffoux, et al.British Journal of Haematology|June 19, 2013
Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-HématologiqueMichael Darmon, François Vincent, Laurent Camous, et al.Haematologica|December 18, 2009
Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des MyelodysplasiesCharikleia Kelaidi, Aspasia Stamatoullas, Odile Beyne-Rauzy, et al.Leukemia Research|June 1, 2012
Outcome of treatment after first relapse in younger adults with acute myeloid leukemia initially treated by the ALFA-9802 trialXavier Thomas, Emmanuel Raffoux, Aline Renneville, et al.Oncotarget|May 18, 2017
BCL2L10 positive cells in bone marrow are an independent prognostic factor of azacitidine outcome in myelodysplastic syndrome and acute myeloid leukemiaValérie Vidal, Guillaume Robert, Laure Goursaud, et al.Blood|February 14, 2019
Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrationsJonas Samuel Jutzi, Titiksha Basu, Maximilian Pellmann, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2017
Randomized Phase II Study of Clofarabine-Based Consolidation for Younger Adults With Acute Myeloid Leukemia in First RemissionXavier Thomas, Stéphane de Botton, Sylvie Chevret, et al.Pageof 17